Ongoing research and clinical trials are exploring the use of Keytruda in combination with other therapies, such as chemotherapy, targeted therapy, and other immunotherapies. The aim is to enhance its efficacy and expand its use to a broader range of cancers. The future looks promising as scientists continue to unravel the complexities of the immune system and its interactions with cancer cells.
